LI
RCUS icon

Leap Investments’s Arcus Biosciences RCUS Stock Holding History

Leap Investments’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$532K Buy
+21,500
New +$580K 0.35% 100

Other funds holding RCUS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Leap Investments's RCUS Position: Q2 2020 in Review

Leap Investments opened a new position in Arcus Biosciences (RCUS) in Q2 2020: 21,500 shares worth $532K. The stake represents 0.35% of the portfolio and ranks #100 among its holdings.

139 funds tracked by Wall St. Rank hold RCUS as of Q2 2020.

  • Leap Investments held 21,500 shares of Arcus Biosciences worth $532K as of Q2 2020.
  • Arcus Biosciences was a new Leap Investments position in Q2 2020.
  • Arcus Biosciences made up 0.35% of Leap Investments's portfolio in Q2 2020, its #100 holding.
  • 139 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.